AllSight
Companies · TECX · Biological Products, (No Diagnostic Substances)

Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Tectonic Therapeutic, Inc. (TECX) stock — financials & valuation

Key numbers for Tectonic Therapeutic, Inc. (TECX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 43/100 — a percentile rank of Tectonic Therapeutic, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$443.2M
EV / EBITDA-2.3×
Return on equity-38.3%
ROIC3138.8%
Debt / equity0.0×
Dividend yield0.0%

Independent of the events above — derived from Tectonic Therapeutic, Inc.’s own financial statements and shown as context, never as advice.

Sep 29, 2026At the bar
Tectonic Therapeutic Phase 1 results clear safety bar, but efficacy remains untested
Related companies in Biological Products, (No Diagnostic Substances)
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact